Transcatheter Aortic Valve Replacement in Moderate-risk Aortic Stenosis Patients
2011 ◽
Vol 9
(1)
◽
pp. 41
◽
Keyword(s):
The Placement of Aortic Transcatheter Valves (PARTNER) trial showed the effectiveness of transcatheter aortic valve replacement (TAVR) for inoperable patients and non-inferiority for mortality versus open valve replacement. There are three questions concerning the role of TAVR for intermediate-risk patients. These relate to: institutional and surgeon results, physician and hospital alignments, and who will pay.
2015 ◽
Vol 66
(14)
◽
pp. 1638
◽
2019 ◽
Vol 74
(13)
◽
pp. B2
2016 ◽
Vol 6
(5)
◽
pp. 459-461
◽
2017 ◽
Vol 70
(18)
◽
pp. B141-B142
2017 ◽
Vol 376
(14)
◽
pp. 1321-1331
◽
2021 ◽
Vol 77
(18)
◽
pp. 1128